At Forbes Healthcare Summit, Epic CEO Judy Faulkner explained why the company’s long-protected independence and unconventional management approach have been central to its dominance as an EHR vendor. Now, she says the company’s future will depends on how it uses its massive data stores to support AI-powered clinical decisions.
It's important to manage one's reputation on social media. Forbes published an amusing guide on biotech investment etiquette.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.
What was the best new drug of 2014? Forbes‘ Matthew Herper chose two. Herper laid out a solid case for why two new – and highly similar – cancer drugs are standouts this year: Keytruda from Merck and Opdivo from Bristol-Myers Squibb. He writes: These two medicines represent a breakthrough in oncology: unlocking the immune system as a […]
Electronic health records might actually be forced to enter the era of interoperability, but it’ll take time, a Forbes piece opines. The new, $1.1 trillion”cromnibus” spending bill that Obama signed this month says regulators must decertify EHRS that hinder device interoperability. The law apportions $60 million to help put this into action, stating that regulators “should take steps to […]
The pharma industry just got a hell of a lot nerdier, thanks to a recent Forbes op-ed. It likens the maze-like research and development quagmire to the elf-infused quests seen in fantasy role-playing game Dungeons and Dragons. Chances are slim for biotechs to make it through the high-stakes R&D game alive. Same goes for the goblins of D&D. The story goes: Dungeons […]